Pfizer’s stock has become a case study in how quickly a pharmaceutical dividend can move from safe to uncertain. The company trades near multi-year lows after acquiring Seagen for forty-three billion dollars and facing patent […]
Pfizer dividend faces pressure as pipeline transitions and debt weighs Read More »
Johnson & Johnson raised its quarterly dividend to $1.34 per share, the 64th consecutive year of increases, with a payout ratio near 59 percent and payment due June 9, 2026.
Johnson & Johnson raised its full-year 2026 guidance after posting stronger-than-expected results in its medical device segment. The healthcare conglomerate now expects faster earnings growth than it projected three months ago, sending a signal that
Johnson & Johnson raises 2026 guidance: what dividend investors should know Read More »
AMN Healthcare Services earned a Zacks Rank #1 Strong Buy designation on May 8, 2026, after analysts revised earnings estimates sharply higher. The company, which provides travel nursing and healthcare staffing solutions, now carries a
AMN Healthcare Rallies on 32% EPS Growth as Staffing Demand Accelerates Read More »
Johnson and Johnson shares gained 4.2% this week after announcing a $6.5 billion settlement. The agreement resolves talc-related lawsuits that have weighed on the stock for years. For conservative healthcare investors, the settlement removes a
Johnson and Johnson stock climbs after $6.5B talc settlement removes legal overhang Read More »
Get free professional market insights and stock/ETF reports that contain actionable opportunities written by a former financial advisor and Capitalist who has been investing in the markets for 20+ years.
Get Free Stock Picks, Macro Market Events & Options Strategies.
